BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 27053560)

  • 1. Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.
    Phillips AT; Rico AB; Stauft CB; Hammond SL; Aboellail TA; Tjalkens RB; Olson KE
    J Virol; 2016 Jun; 90(12):5785-96. PubMed ID: 27053560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry.
    Salimi H; Cain MD; Jiang X; Roth RA; Beatty WL; Sun C; Klimstra WB; Hou J; Klein RS
    mBio; 2020 Feb; 11(1):. PubMed ID: 32047126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioluminescent imaging and histopathologic characterization of WEEV neuroinvasion in outbred CD-1 mice.
    Phillips AT; Stauft CB; Aboellail TA; Toth AM; Jarvis DL; Powers AM; Olson KE
    PLoS One; 2013; 8(1):e53462. PubMed ID: 23301074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
    Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse.
    Charles PC; Walters E; Margolis F; Johnston RE
    Virology; 1995 Apr; 208(2):662-71. PubMed ID: 7747437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
    Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
    J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus.
    Gupta P; Sharma A; Han J; Yang A; Bhomia M; Knollmann-Ritschel B; Puri RK; Maheshwari RK
    BMC Infect Dis; 2017 Apr; 17(1):309. PubMed ID: 28446152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the blood-brain barrier during Venezuelan equine encephalitis virus infection.
    SchÀfer A; Brooke CB; Whitmore AC; Johnston RE
    J Virol; 2011 Oct; 85(20):10682-90. PubMed ID: 21849461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates.
    Smith DR; Schmaljohn CS; Badger C; Ostrowski K; Zeng X; Grimes SD; Rayner JO
    Antiviral Res; 2020 Oct; 182():104875. PubMed ID: 32755661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Quantitative Real-Time RT-PCR Assay for the Detection of
    Vina-Rodriguez A; Eiden M; Keller M; Hinrichs W; Groschup MH
    Biomed Res Int; 2016; 2016():8543204. PubMed ID: 28042576
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
    Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
    Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus entry and replication in the brain precedes blood-brain barrier disruption during intranasal alphavirus infection.
    Cain MD; Salimi H; Gong Y; Yang L; Hamilton SL; Heffernan JR; Hou J; Miller MJ; Klein RS
    J Neuroimmunol; 2017 Jul; 308():118-130. PubMed ID: 28501330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
    Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
    Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.
    Baer A; Lundberg L; Swales D; Waybright N; Pinkham C; Dinman JD; Jacobs JL; Kehn-Hall K
    J Virol; 2016 Jan; 90(7):3558-72. PubMed ID: 26792742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding host responses to equine encephalitis virus infection: implications for therapeutic development.
    Kehn-Hall K; Bradfute SB
    Expert Rev Anti Infect Ther; 2022 Dec; 20(12):1551-1566. PubMed ID: 36305549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of Venezuelan Equine Encephalitis Virus Genome Using Two Methods.
    Behnia M; Baer A; Skidmore AM; Lehman CW; Bracci N; Kehn-Hall K; Bradfute SB
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infection.
    Amaya M; Keck F; Lindquist M; Voss K; Scavone L; Kehn-Hall K; Roberts B; Bailey C; Schmaljohn C; Narayanan A
    PLoS One; 2015; 10(4):e0124792. PubMed ID: 25927990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralising antibodies for Mayaro virus in Pantanal, Brazil.
    Pauvolid-CorrĂȘa A; Juliano RS; Campos Z; Velez J; Nogueira RM; Komar N
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):125-33. PubMed ID: 25742272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection.
    Painter GR; Bowen RA; Bluemling GR; DeBergh J; Edpuganti V; Gruddanti PR; Guthrie DB; Hager M; Kuiper DL; Lockwood MA; Mitchell DG; Natchus MG; Sticher ZM; Kolykhalov AA
    Antiviral Res; 2019 Nov; 171():104597. PubMed ID: 31494195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.